# Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer

> **NCT03115593** · NA · WITHDRAWN · sponsor: **Brugmann University Hospital**

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** Blind biopsy with a pipette
- **PROCEDURE:** Targeted biopsy using hysteroscopy

## Key facts

- **NCT ID:** NCT03115593
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07-10
- **Primary completion:** 2020-03-02
- **Final completion:** 2020-03-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of human ressources
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115593, "Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03115593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*